ALPK2 and urinary bladder carcinoma: Subsequent in vitro experiments validated the role of ALPK2 in bladder cancer via uncovering the inhibition of cell proliferation and cell motility, and the promotion of cell apoptosis induced by ALPK2 knockdown.